NCT03924895 · Interventional trial
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
Overall registry status Active not recruiting
Phase 3
Conditions Urinary Bladder Cancer, Muscle-invasive
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania ( Site 0074) · Philadelphia, PA · Philadelphia County
- Fox Chase Cancer Center ( Site 0055) · Philadelphia, PA · Philadelphia County
- MidLantic Urology ( Site 0089) · Bala-Cynwyd, PA · Montgomery County
- Thomas Jefferson University ( Site 1579) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory